[3] He was a member of many pharmacological associations around the world and since 1993 president of the Jagiellonian Medical Research Centre (Jagiellońskie Centrum Badań Medycznych).

[5] Together with Andrzej Szczeklik, he was involved in the research on the so-called “aspirin-induced asthma” (AIA) and contributed to the concept that this disease is not caused by sensitization to nonsteroidal anti-inflammatory drugs but results from the inhibition of the cyclooxygenase type 1 (COX-1) pathway.

[6] Among his other notable discoveries was the fact that antiplatelet drugs, such as Clopidogrel, exert a strong fibrynolitic effect in the mechanism depentent on the endothelial cells.

[9] In 2002, he received the Grand Cross of the Order of Polonia Restituta from President Aleksander Kwaśniewski for "outstanding merits in his scientific and didactical work".

[11] On 20 January 2017, he was awarded Poland's highest decoration, the Order of the White Eagle, by President Andrzej Duda for his "distinguished contributions to the development of pharmacology and clinical medicine".